Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants

CompletedOBSERVATIONAL
Enrollment

231

Participants

Timeline

Start Date

February 7, 2012

Primary Completion Date

November 26, 2018

Study Completion Date

November 26, 2018

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
BIOLOGICAL

natalizumab

Natalizumab will not be provided as a part of this study. Participants will receive natalizumab as prescribed by their treating physician.

Trial Locations (44)

10016

Research Site, New York

10021

Research Site, New York

10306

Research Site, Staten Island

11772

Research Site, Patchogue

11794

Research Site, Stony Brook

11803

Research Site, Plainview

19713

Research Site, Newark

20007

Research Site, Washington D.C.

21287

Research Site, Baltimore

23502

Research Site, Norfolk

23601

Research Site, Newport News

30309

Research Site, Atlanta

32209

Research Site, Jacksonville

35209

Research Site, Homewood

40207

Research Site, Louisville

43230

Research Site, Gahanna

44195

Research Site, Cleveland

44685

Research Site, Uniontown

45219

Research Site, Cincinnati

46256

Research Site, Indianapolis

46260

Research Site, Indianapolis

48824

Research Site, East Lansing

60010

Research Site, Lake Barrington

60612

Research Site, Chicago

61603

Research Site, Peoria

66212

Research Site, Overland Park

68521

Research Site, Lincoln

70121

Research Site, New Orleans

75235

Research Site, Dallas

78681

Research Site, Round Rock

80045

Research Site, Aurora

80528

Research Site, Fort Collins

84103

Research Site, Salt Lake City

85351

Research Site, Sun City

90032

Research Site, Los Angeles

92037

Research Site, La Jolla

97225

Research Site, Portland

98101

Research Site, Seattle

98405

Research Site, Tacoma

02215

Research Site, Boston

02421

Research Site, Lexington

02481

Research Site, Wellesley Hills

01655

Research Site, Worcester

07728

Research Site, Freehold

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY